After already halving its workforce twice since 2022, Sensei Therapeutics is forging ahead with another deep round of cuts. The biotech on Friday said 65% of its staffers are set to leave the company.

BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (SNSE), a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for ...

Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its options. Two weeks ago, the biotech reported phase 1/2 data for its ...

BOSTON - Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) announced Thursday it will discontinue development of its cancer drug solnerstotug and initiate a strategic review to maximize shareholder value.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Lockhart officials are heralding ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Los Angeles-based Sensei was ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...

Bill Dumas took off his apron, then his shirt and undershirt, while walking away from the booth where he was serving sausage at the 2022 Monterrey BBQ Fest, in Mexico. Under the hot afternoon sun, he ...

Travelers are chasing more than rest; they want lasting vitality. Alexandra Walterspiel is betting that the future of luxury lies in wellness, and her approach at Sensei hints at where high-end ...

Casa Sensei, located in the heart of Las Olas in Fort Lauderdale, blends Latin American soul with Pan-Asian flair, and it's not shy about it. With dining available indoors and dockside, the restaurant ...